Article: HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda Published in: PLoS Med. 2021;18(2):e1003492 https://doi.org/10.1371/journal.pmed.1003492 Authors: Koss CA,...
Chammartin F, Lodi S, Logan R, Ryom L, Mocroft A, Kirk O, d’Arminio Monforte A, Reiss P, Phillips A, El-Sadr W, Hatleberg CI, Pradier C, Bonnet F, Law M, De Wit S, Sabin C, Lundgren JD, Bucher HC. Ann Intern Med. 2021 Mar 16. doi: 10.7326/M20-5226. Epub ahead...
Teasdale CA, Geller A, Shongwe S, Mafukidze A, Choy M, Magaula B, Yuengling K, King K, De Gusmao EP, Ryan C, Ao T, Callahan T, Modi S, Abrams EJ. PLoS One. 2021 Mar 24;16(3):e0248685. doi: 10.1371/journal.pone.0248685. PMID: 33760864. Abstract Background: Uptake and...
Article: Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study Published in: Lancet HIV. 2021;8(2):e87-e95 https://doi.org/10.1016/S2352-3018(20)30304-0 Authors: Baeten JM, Palanee-Phillips T,...
Article and Study Summary Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study Published in: Lancet. 2020;396 (10267):1994-2005...
